IT1153181B - Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana - Google Patents

Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana

Info

Publication number
IT1153181B
IT1153181B IT23016/82A IT2301682A IT1153181B IT 1153181 B IT1153181 B IT 1153181B IT 23016/82 A IT23016/82 A IT 23016/82A IT 2301682 A IT2301682 A IT 2301682A IT 1153181 B IT1153181 B IT 1153181B
Authority
IT
Italy
Prior art keywords
pharmaceutical formulations
human
formulations including
proinsulin
human insulin
Prior art date
Application number
IT23016/82A
Other languages
English (en)
Other versions
IT8223016A0 (it
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IT8223016A0 publication Critical patent/IT8223016A0/it
Application granted granted Critical
Publication of IT1153181B publication Critical patent/IT1153181B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT23016/82A 1981-08-27 1982-08-27 Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana IT1153181B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671481A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
IT8223016A0 IT8223016A0 (it) 1982-08-27
IT1153181B true IT1153181B (it) 1987-01-14

Family

ID=23143234

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23016/82A IT1153181B (it) 1981-08-27 1982-08-27 Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana

Country Status (20)

Country Link
US (1) US4652547A (it)
JP (1) JPS5846025A (it)
AU (1) AU551733B2 (it)
BE (1) BE894188A (it)
CA (1) CA1176161A (it)
CH (1) CH650678A5 (it)
DE (1) DE3232033A1 (it)
DO (1) DOP1982004086A (it)
FR (1) FR2511867B1 (it)
GB (1) GB2105191B (it)
IL (1) IL66613A (it)
IT (1) IT1153181B (it)
LU (1) LU84356A1 (it)
MW (1) MW4082A1 (it)
NL (1) NL8203314A (it)
NZ (1) NZ201686A (it)
PH (1) PH18725A (it)
SE (1) SE8204874L (it)
ZA (1) ZA826158B (it)
ZW (1) ZW17582A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DOP1982004086A (es) * 1981-08-27 1988-03-22 Lilly Co Eli Formula farmaceutica que comprende insulina humana y proinsulina humana
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
WO1990012091A1 (en) * 1989-04-07 1990-10-18 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor
US5208217A (en) * 1989-04-20 1993-05-04 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
WO1997011959A1 (en) * 1995-09-29 1997-04-03 Receptron, Inc. Biologically active mhc peptides having a repeated amino acid sequence motif
TR200400295T2 (tr) * 2001-05-21 2005-04-21 Nektar Therapeutics Kimyasal olarak modifiye edilmiş ensülin'in akçiğer yoluyla verilmesi
EP1429763B1 (en) 2001-09-14 2007-05-30 Novo Nordisk A/S NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
US7670984B2 (en) * 2006-01-06 2010-03-02 Headwaters Technology Innovation, Llc Hydrocarbon-soluble molybdenum catalyst precursors and methods for making same
IL186598A0 (en) * 2007-10-11 2008-11-03 Mohammad Abdulrazik Composition and method for the treatment or prevention of glaucoma and ocular hypertension
US9939551B2 (en) 2012-09-24 2018-04-10 Schlumberger Technology Corporation Systems, devices and methods for borehole gravimetry
CN105073129A (zh) * 2013-01-29 2015-11-18 奥莎迪药品管理有限公司 用于糖尿病的口服治疗的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183849A (en) * 1975-01-15 1980-01-15 Nordisk Insulinlaboratorium Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
DOP1982004086A (es) * 1981-08-27 1988-03-22 Lilly Co Eli Formula farmaceutica que comprende insulina humana y proinsulina humana

Also Published As

Publication number Publication date
IL66613A (en) 1985-11-29
AU551733B2 (en) 1986-05-08
BE894188A (fr) 1983-02-24
LU84356A1 (fr) 1983-02-28
DOP1982004086A (es) 1988-03-22
US4652547A (en) 1987-03-24
NZ201686A (en) 1985-08-30
MW4082A1 (en) 1984-06-13
SE8204874L (sv) 1983-02-28
AU8759682A (en) 1983-03-03
IT8223016A0 (it) 1982-08-27
NL8203314A (nl) 1983-03-16
ZW17582A1 (en) 1982-11-17
FR2511867B1 (fr) 1986-08-14
FR2511867A1 (fr) 1983-03-04
GB2105191A (en) 1983-03-23
PH18725A (en) 1985-09-11
IL66613A0 (en) 1982-12-31
CH650678A5 (de) 1985-08-15
DE3232033A1 (de) 1983-03-10
JPS5846025A (ja) 1983-03-17
CA1176161A (en) 1984-10-16
GB2105191B (en) 1984-12-19
ZA826158B (en) 1984-04-25
SE8204874D0 (sv) 1982-08-25

Similar Documents

Publication Publication Date Title
IT1153181B (it) Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana
DK215983A (da) Praeparater til hudpleje
IT1153182B (it) Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano
GB2104380B (en) Human proinsulin pharmaceutical formulations
ZW17682A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin
JO1236B1 (en) Pharmacy formulations that include human insulin and a human-c-peptide
JO1209B1 (en) Pharmacy formulations that include human insulin and the human insulin component.
JO1238B1 (en) Pharmacy formulations include human insulin, human peptide-C and the human insulin component